Astellas Pharma Submits New Drug Application for Avacincaptad Pegol in Japan Astellas Pharma has submitted a New Drug Application for avacincaptad pegol, which may be the first treatment for geographic atrophy in Japan. This is a notable step for AMD patients.

Astellas Pharma Submits New Drug Application for Avacincaptad Pegol in Japan #Japan #Tokyo #Astellas #Geographic_Atrophy #Avacincaptad